Medtronic ROA 2006-2019 | MDT
Current and historical return on assets (ROA) values for Medtronic (MDT) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Medtronic ROA for the three months ending April 30, 2019 was 7.96%.
| Medtronic ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2019-04-30 | $4.63B | $89.69B | 5.20% |
| 2019-01-31 | $4.92B | $88.73B | 5.50% |
| 2018-10-31 | $2.26B | $88.15B | 2.48% |
| 2018-07-31 | $3.16B | $89.72B | 3.41% |
| 2018-04-30 | $3.10B | $91.39B | 3.25% |
| 2018-01-31 | $2.81B | $95.80B | 2.88% |
| 2017-10-31 | $5.02B | $94.46B | 5.12% |
| 2017-07-31 | $4.12B | $100.25B | 4.16% |
| 2017-04-30 | $4.03B | $99.86B | 4.08% |
| 2017-01-31 | $3.97B | $97.58B | 4.03% |
| 2016-10-31 | $4.24B | $98.41B | 4.25% |
| 2016-07-31 | $3.65B | $98.60B | 3.59% |
| 2016-04-30 | $3.54B | $99.64B | 3.44% |
| 2016-01-31 | $2.43B | $102.71B | 2.32% |
| 2015-10-31 | $2.32B | $104.95B | 2.49% |
| 2015-07-31 | $2.62B | $104.63B | 3.44% |
| 2015-04-30 | $2.68B | $106.69B | 4.49% |
| 2015-01-31 | $3.12B | $55.23B | 7.37% |
| 2014-10-31 | $2.91B | $38.78B | 7.68% |
| 2014-07-31 | $2.98B | $37.55B | 8.00% |
| 2014-04-30 | $3.07B | $37.94B | 8.36% |
| 2014-01-31 | $3.59B | $37.23B | 9.99% |
| 2013-10-31 | $3.81B | $36.47B | 10.79% |
| 2013-07-31 | $3.56B | $34.97B | 10.25% |
| 2013-04-30 | $3.47B | $34.90B | 10.12% |
| 2013-01-31 | $3.49B | $34.95B | 10.34% |
| 2012-10-31 | $3.44B | $33.96B | 10.41% |
| 2012-07-31 | $3.66B | $33.25B | 11.28% |
| 2012-04-30 | $3.62B | $32.82B | 11.34% |
| 2012-01-31 | $3.40B | $31.91B | 10.85% |
| 2011-10-31 | $3.39B | $31.75B | 10.93% |
| 2011-07-31 | $3.09B | $31.09B | 10.15% |
| 2011-04-30 | $3.10B | $30.68B | 10.39% |
| 2011-01-31 | $3.28B | $30.60B | 11.23% |
| 2010-10-31 | $3.18B | $29.31B | 11.44% |
| 2010-07-31 | $3.48B | $28.66B | 13.12% |
| 2010-04-30 | $3.10B | $28.09B | 12.26% |
| 2010-01-31 | $2.25B | $25.17B | 9.30% |
| 2009-10-31 | $2.11B | $24.28B | 8.97% |
| 2009-07-31 | $1.79B | $23.57B | 7.79% |
| 2009-04-30 | $2.07B | $23.59B | 9.09% |
| 2009-01-31 | $2.69B | $22.76B | 11.98% |
| 2008-10-31 | $2.07B | $22.03B | 9.36% |
| 2008-07-31 | $2.19B | $22.73B | 10.06% |
| 2008-04-30 | $2.14B | $22.20B | 10.20% |
| 2008-01-31 | $2.23B | $21.41B | 10.99% |
| 2007-10-31 | $2.86B | $20.59B | 14.44% |
| 2007-07-31 | $2.88B | $19.66B | 14.83% |
| 2007-04-30 | $2.80B | $19.51B | 14.34% |
| 2007-01-31 | $2.73B | $19.57B | 13.94% |
| 2006-10-31 | $2.69B | $18.90B | 13.95% |
| 2006-07-31 | $2.83B | $20.18B | 14.88% |
| 2006-04-30 | $2.55B | $19.67B | 14.02% |
| 2006-01-31 | $2.00B | $18.34B | 11.50% |
| 2005-10-31 | $1.88B | $17.77B | 11.21% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $137.817B | $30.557B |
| Medtronic Public Limited Company, headquartered in Dublin, Ireland, is among the world's largest medical technology, services and solutions companies - alleviating pain, restoring health and extending life for millions of people around the world. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $149.840B | 28.17 |
| Stryker (SYK) | United States | $81.180B | 28.07 |
| Boston Scientific (BSX) | United States | $58.714B | 28.48 |
| Baxter (BAX) | United States | $44.403B | 26.93 |
| EssilorLuxottica Societe Anonyme (ESLOY) | France | $30.829B | 0.00 |
| Zimmer Biomet Holdings (ZBH) | United States | $28.130B | 18.00 |
| Coloplast (CLPBY) | Denmark | $26.395B | 42.14 |
| Lonza Group Ag (LZAGY) | Switzerland | $26.038B | 0.00 |
| Terumo (TRUMY) | Japan | $23.788B | 27.35 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $20.267B | 0.00 |
| ResMed (RMD) | United States | $19.315B | 36.83 |
| Sunny Optical Technology (SNPTF) | China | $13.689B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $9.759B | 52.32 |
| Canopy Growth (CGC) | Canada | $9.745B | 0.00 |
| Insulet (PODD) | United States | $9.055B | 536.57 |
| William Demant Holdings (WILYY) | Denmark | $7.136B | 0.00 |
| Haemonetics (HAE) | United States | $7.033B | 53.07 |
| Hill-Rom Holdings (HRC) | United States | $7.032B | 20.97 |
| Perrigo (PRGO) | Ireland | $6.283B | 11.57 |
| Aurora Cannabis (ACB) | Canada | $6.094B | 59.90 |
| GN STORE NORD (GNNDY) | Denmark | $5.897B | 30.11 |
| GW Pharmaceuticals (GWPH) | United Kingdom | $4.651B | 0.00 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $4.296B | 0.00 |
| Neogen (NEOG) | United States | $3.710B | 61.70 |
| ICU Medical (ICUI) | United States | $3.430B | 22.25 |
| NuVasive (NUVA) | United States | $3.316B | 26.44 |
| Hutchison China MediTech (HCM) | China | $2.737B | 0.00 |
| Quidel (QDEL) | United States | $2.552B | 25.34 |
| Agios Pharmaceuticals (AGIO) | United States | $2.491B | 0.00 |
| National Vision Holdings (EYE) | United States | $2.177B | 46.98 |
| Cardiovascular Systems (CSII) | United States | $1.682B | 0.00 |
| Aphria (APHA) | $1.551B | 0.00 | |
| Phibro Animal Health (PAHC) | United States | $1.263B | 18.92 |
| AtriCure (ATRC) | United States | $1.060B | 0.00 |
| VAREX IMAGING (VREX) | United States | $1.018B | 23.45 |
| NanoString Technologies (NSTG) | United States | $0.977B | 0.00 |
| Omeros (OMER) | United States | $0.967B | 0.00 |
| PetIQ (PETQ) | United States | $0.908B | 21.44 |
| Lantheus Holdings (LNTH) | United States | $0.897B | 23.57 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.794B | 20.23 |
| Cerus (CERS) | United States | $0.769B | 0.00 |
| MacroGenics (MGNX) | United States | $0.737B | 0.00 |
| Quanterix (QTRX) | United States | $0.702B | 0.00 |
| TG Therapeutics (TGTX) | United States | $0.648B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $0.626B | 37.08 |
| Surmodics (SRDX) | United States | $0.601B | 114.26 |
| OraSure Technologies (OSUR) | United States | $0.446B | 20.63 |
| Meridian Bioscience (VIVO) | United States | $0.432B | 13.48 |
| Neptune Technologies & Bioresources Inc (NEPT) | Canada | $0.423B | 0.00 |
| BioLife Solutions (BLFS) | United States | $0.376B | 123.63 |
| United Health Products (UEEC) | United States | $0.350B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.349B | 25.56 |
| Zynex (ZYXI) | United States | $0.345B | 36.62 |
| Owens & Minor (OMI) | United States | $0.306B | 9.17 |
| Bovie Medical (APYX) | United States | $0.251B | 0.00 |
| Vapotherm (VAPO) | United States | $0.244B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.155B | 0.00 |
| Chimerix (CMRX) | United States | $0.153B | 0.00 |
| Fonar (FONR) | United States | $0.152B | 8.01 |
| Rockwell Medical (RMTI) | United States | $0.152B | 0.00 |
| Female Health (VERU) | United States | $0.123B | 0.00 |
| InfuSystems Holdings (INFU) | United States | $0.099B | 0.00 |
| Chembio Diagnostics (CEMI) | United States | $0.097B | 0.00 |
| United-Guardian (UG) | United States | $0.087B | 20.65 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.057B | 0.00 |
| Surface Oncology (SURF) | United States | $0.055B | 0.00 |
| Nephros (NEPH) | United States | $0.054B | 0.00 |
| MRI INTERVENTNS (MRIC) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.041B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.041B | 14.17 |
| Senestech (SNES) | United States | $0.039B | 0.00 |
| Valeritas Holdings (VLRX) | United States | $0.013B | 0.00 |
| Myomo (MYO) | United States | $0.011B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.011B | 0.00 |
| Conatus Pharmaceuticals (CNAT) | United States | $0.010B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.006B | 0.00 |
| Akers Biosciences Inc (AKER) | United States | $0.005B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.003B | 0.00 |
